Alternative Names for Fosinopril-HCTZ
Fosinopril sodium and hydrochlorothiazide is also known as Monopril-HCT, which is the brand name for this fixed-dose combination medication.
This combination medication consists of two active ingredients:
- Fosinopril sodium - an angiotensin-converting enzyme (ACE) inhibitor
- Hydrochlorothiazide (HCTZ) - a thiazide diuretic
Clinical Information About This Combination
This fixed-dose combination is used in the management of hypertension, where:
- Fosinopril works by inhibiting the renin-angiotensin system, reducing vasoconstriction and sodium retention 1
- HCTZ complements this action by increasing sodium and water excretion through the kidneys
Dosage Information
The typical dosage forms available include:
Clinical Considerations
- This combination provides synergistic antihypertensive effects, as demonstrated in clinical studies 2
- The dual route of elimination of fosinoprilat (the active metabolite of fosinopril) through both hepatic and renal pathways makes it particularly useful in patients with moderate renal impairment 3
- Unlike some other ACE inhibitors that require dose adjustment in renal impairment, fosinopril may not require dosage modifications due to its compensatory elimination pathway 3
Important Precautions
- ACE inhibitors including fosinopril are contraindicated in pregnancy 4
- Monitor serum potassium and renal function within 3 months of starting this combination 4
- If eGFR is <30 mL/min/m², a loop diuretic should be considered instead of HCTZ 1
This fixed-dose combination represents an effective option for hypertension management, particularly in patients who require multiple agents to achieve blood pressure control.